课题基金 / 基金详情

Point mutations of the AML1 gene in patients with leukemia : implications in leukemogenesis, progression, and recurrence

Point mutations of the AML1 gene in patients with leukemia : implications in leukemogenesis, progression, and recurrence
白血病患者 AML1 基因的点突变:对白血病发生、进展和复发的影响
批准号:
12670996
负责人:
ASOU Norio
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

ASOU Norio的其他基金

相似基金

相关文献

中文摘要
翻译
Run结构域Transseriptibn因子AML1/RUNX1对于定向造血干细胞的产生和分化是必不可少的。AML1是急性白血病最常见的染色体易位靶点。一些嵌合蛋白,如AML1-MTG8和TEL-AML1,具有野生型AML1的易位特性,并作为转录抑制因子。另一方面,在非AML1易位的散发性急性髓母细胞白血病(AML)和伴有AML易感性的家族性血小板疾病(FPD/AML)中都发现了AML1 Run结构域的突变。在这项研究中,我们在25例急性髓系白血病M0亚型患者中发现了5例AML1基因突变(20%)。我们还在2个FPD/AML家系中发现了AML1基因突变。这些观察表明,由于染色体易位或突变而导致的AML1剂量的减少有助于白血病的发生。对FPD/AML家系AML1突变的功能分析表明,AML1基因有两种类型的突变:功能丧失突变(单倍体功能不全)和显性阴性突变形式。具有AML1基因显性负性错义突变的家系与AML1基因真正单倍性缺失和移码突变等家系相比,具有更高的AML发病风险。这些观察表明,AML1的剂量对于获得导致AML的第二次突变至关重要,尽管这一分子机制仍有待确定。P15基因甲基化在急性髓细胞白血病中经常被观察到,是刺激细胞增殖的第二个突变的候选。我们正在用实时定量RT-PCR方法分析p15基因在AML中的表达。我们还检测了从骨髓增生异常综合征和复发性AML急性转化患者中AML1基因的突变。
英文摘要
A Runt domain transeriptibn factor AML1/RUNX1 is essential for generation and differentiation of difinitive hematopoietic stem cells. AML1 is the most frequent target of chromosomal translocations in acute leukemias. Several chimericproteins such as AML1-MTG8 and TEL-AML1 have transdominant properties for wild-type AML1 and acts as transcriptional repressors. On the other hand, mutations in the Runt domain of the AML1 are identified in both sporadic acute myeloblastic leukemia (AML) without AML1 translocation and familial platelet disorder with predisposition to AML (FPD/AML). In this study, we identified mutations of the AML1 gene in 5 of 25 (20%) patients with AML M0 subtype. We also found mutations of the AML1 gene in 2 pidigrees of FPD/AML. These observations indicate that a decrease in AML1 dosage resulting from chromosomal translocations or mutations contributes to leukemogenesis. Functional analysis of AML1 mutants in the FPD/AML pedigrees showed two types of mutations of the AML1 gene : loss-of-function mutations (haploinsufficiency) and a dominant negative forms of mutations. Pedigrees with dominant negative missense mutation of the AML1 appear to have a higher insidence of development of AML than those in families with genuine haploinsufficiency of the AML1 gene such as deletions and frameshift mutations. These observations suggest that dosage of AML1 is critical for acquisition of second mutation leading to AML although this molecular mechanism remains to be determined. Methylation of the p15 gene, which is frequently observed in AML, is candidate for second mutation that should stimulate cell proliferation. We are analyzing p15 mRNA expression in AML by using quantitative assay with real-time RT-PCR. We have also examined mutations of the AML1 gene in patients with acute transformation from myelodysplastic syndrome and relapsing AML.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
Yokozawa T,Asou N, et al: "Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia."Leukemia. 14. 28-33 (2000)
Yokozawa T、Asou N 等人:“细胞周期抑制剂 p27Kip1 在急性髓系白血病中的预后意义。”白血病。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hoshino K, Asou N, et al.: "The absence of the p15INK4B gene alterations in adult patients with precursor B-cell acute lymphoblastic leukaemia is a fovorable prognostic factor"Br J Haematol. (in press,発表予定). (2002)
Hoshino K、Asou N 等人:“前体 B 细胞急性淋巴细胞白血病成人患者中缺乏 p15INK4B 基因改变是一个有利的预后因素”Br J Haematol(出版中,待出版)。 )
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takeshita A,Asou N, et al: "Quantitative expression of erythropoietin receptor (EPO-R) on acute leukaemia cells : relationships between the amount of EPO-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clin
Takeshita A、Asou N 等人:“急性白血病细胞上促红细胞生成素受体 (EPO-R) 的定量表达:EPO-R 的量与 CD 表型、体外增殖反应、其他细胞因子受体的量与临床的关系
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Naoe T, Asou N, et al.: "Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia : increased early death after chemotherapy"Leukemia. 16. 203-208 (2002)
Naoe T、Asou N 等人:“急性髓系白血病患者中谷胱甘肽 S-转移酶-T1 无效基因型的预后意义:化疗后早期死亡增加”白血病。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 21 条
    Prognostic implications of the genetic abnormalities in adult patients with acute lymphoblastic leukemia
    Prognostic implication of gene mutations in patients with acute myeloid leukemia
    • 批准号:
      20591136
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      ASOU Norio
    • 依托单位:
    Analysis of the mechanism of leukemogenesis in leukemia cells carrying mutation of AML1 and PEBP2β genes
    • 批准号:
      10670958
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      1998
    • 负责人:
      ASOU Norio
    • 依托单位:
    海外基金